{
  "ticker": "JNJ",
  "target_date": "2025-05-06",
  "actual_date": "2025-05-06",
  "collected_at": "2025-12-08T11:43:39.979345",
  "price": {
    "open": 151.42,
    "high": 152.48,
    "low": 150.32,
    "close": 151.08175659179688,
    "volume": 8644200,
    "change_1d_pct": -0.34,
    "change_7d_pct": -0.07,
    "change_30d_pct": -5.4
  },
  "technicals": {
    "rsi_14": 52.78,
    "sma_20": 151.01,
    "sma_50": 155.83,
    "macd": -0.717,
    "macd_signal": -0.945,
    "macd_histogram": 0.228,
    "bb_upper": 155.72,
    "bb_lower": 146.3,
    "price_vs_sma20_pct": 0.05,
    "price_vs_sma50_pct": -3.05,
    "volume_ratio": 0.95
  },
  "fundamentals": {
    "market_cap": 489219391488,
    "pe_ratio": 19.599903,
    "forward_pe": 19.15613,
    "price_to_book": 6.16308,
    "price_to_sales": 5.309004,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.29,
    "pct_from_52w_low": 44.34
  },
  "macro": {
    "spy": {
      "price": 555.61,
      "change_1d_pct": -0.84,
      "change_7d_pct": 1.44
    },
    "vix": {
      "level": 24.76,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.31
    },
    "dollar_index": {
      "level": 99.24
    },
    "gold": {
      "price": 3411.4
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (NYSE:JNJ) Presents Promising TREMFYA Study Results At Digestive Disease Week 2025",
      "source": "Yahoo",
      "datetime": 1746553164,
      "summary": "Johnson & Johnson (NYSE:JNJ) recently presented promising data on TREMFYA\u00ae for ulcerative colitis and Crohn's disease, spotlighting its role in enhancing treatment options. Despite these advancements, the company's share price exhibited a modest 1% increase over the past month, in line with steady m",
      "url": "https://finnhub.io/api/news?id=8826886a98ec68e39a6e18d1d24a585b5601c87f9a5a60e51302993175dd7fb7"
    },
    {
      "headline": "ClearBridge Small Cap Growth Portfolios Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1746540660,
      "summary": "Last year\u00e2\u0080\u0099s pattern of large caps outperforming small caps has continued, although growth leadership has given way to value amid the preference for defense.",
      "url": "https://finnhub.io/api/news?id=d751d18eceef686fde5c9df9f78561bec955383feb2f9e178cb6225b1b8c01f5"
    },
    {
      "headline": "The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific",
      "source": "Yahoo",
      "datetime": 1746537000,
      "summary": "GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific are part of the Zacks top Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=411cc7cdf1e8a3a14b5b8e2c90c29fb78104f225f98456900647d321d893193b"
    },
    {
      "headline": "Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock",
      "source": "Yahoo",
      "datetime": 1746536416,
      "summary": "Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=ab469218bdb47e4a201fae0b626c55dc0c72f9aa40b41ed8abda20d644d9929e"
    },
    {
      "headline": "JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?",
      "source": "Yahoo",
      "datetime": 1746534360,
      "summary": "Both JNJ and ABBV expect their sales and profits to improve in 2025.",
      "url": "https://finnhub.io/api/news?id=334d0accc28e0b489dd375599fb803597bcfcc8689c0be018d7691970fe9b693"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    },
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877141.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000133/xslF345X05/wk-form4_1745877141.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}